1. Home
  2. CGEM vs GES Comparison

CGEM vs GES Comparison

Compare CGEM & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$10.37

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

Logo Guess? Inc.

GES

Guess? Inc.

HOLD

Current Price

$16.75

Market Cap

872.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGEM
GES
Founded
2016
1981
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
671.7M
872.4M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
CGEM
GES
Price
$10.37
$16.75
Analyst Decision
Strong Buy
Buy
Analyst Count
8
5
Target Price
$28.00
$19.88
AVG Volume (30 Days)
1.2M
461.6K
Earning Date
11-06-2025
11-25-2025
Dividend Yield
N/A
5.37%
EPS Growth
N/A
N/A
EPS
N/A
1.07
Revenue
N/A
$3,144,417,000.00
Revenue This Year
N/A
$8.97
Revenue Next Year
N/A
$4.07
P/E Ratio
N/A
$15.65
Revenue Growth
N/A
6.44
52 Week Low
$5.68
$8.48
52 Week High
$13.33
$17.15

Technical Indicators

Market Signals
Indicator
CGEM
GES
Relative Strength Index (RSI) 48.62 41.50
Support Level $9.48 $16.73
Resistance Level $10.38 $16.85
Average True Range (ATR) 0.89 0.07
MACD -0.25 -0.02
Stochastic Oscillator 16.30 8.90

Price Performance

Historical Comparison
CGEM
GES

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About GES Guess? Inc.

Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.

Share on Social Networks: